Cosmos Holdings Inc (NASDAQ: COSM) is an enormous short squeeze that is rocketing up the charts while the overall market are weak. On Monday COSM was up over 10% at one point but closed at $0.57 up 6.5% while the Nasdaq lost just under 500 points on the day. COSM is quickly going viral and is currently among the top most trending stocks on Stocktwits, the top most mentioned stock on the sub reddit Short Squeeze, and there are dozens of Youtube channels reporting on it and private discord groups buying COSM from all over the world. 

While COSM was shorted into oblivion the Company is strong recently reporting $12 million in revenues in Q3 as well as rapid growth through acquisition with 3 major acquisitions currently on the table. COSM is led by able CEO Grigorios Siokas, a high level pharmaceutical executive Mr. Siokas is a major shareholder in Ippokratis Pharmaceuticals, Thrakis Pharmaceuticals, Thessalias Pharmaceuticals, and ZED Pharma SA. Since 2019, Mr. Siokas has invested over $10.6M at an average price of $5.25 of his personal wealth into Cosmos. More recently Mr. Siokas acquired another 1,131,098 shares on Friday adding to the 481,079 shares acquired Thursday adding to his previous buy of 800,000 shares at $0.62 earlier last week. This comes after Mr. Siokas acquired 12.5 million shares price at $0.12 as part of a securities purchase agreement in October.  

COSM Tuesday Update: COSM is coming back moving back over $0.50 in late day trading Tuesday. The stock saw a significant drop this morning after the Company filed an 8k on Monday that stated the board had approved several matters including: “(6) to authorize the Board of Directors to amend the Articles of Incorporation to effect a reverse stock split of the Company’s outstanding common stock at their discretion.” This does not mean COSM is going to do a reverse split. It means the BOD has approved it so they can affect a RS at their discretion if they need to. It’s certainly in managements best interest not to do a reverse stock split. However, the Nasdaq listing is more important so they will use it if they have to. We gave the heads up on COSM when the stock was below $0.10 per share at the beginning of November. We will be updating on COSM as soon as anything new happens so make sure you are subscribed to Microcapdaily by entering your email in the box below.  

Cosmos Holdings Inc (NASDAQ: COSM) is an international healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. The group in engaged in the nutraceuticals sector through its own proprietary lines of products “Sky Premium Life” and “Mediterranation”. Cosmos Holdings Inc. is operating in the pharmaceutical sector as well, through the provision of a broad line of branded generics and OTC medications. In addition, the group is involved in the healthcare distribution sector through its subsidiaries in EU and UK serving retail pharmacies and wholesale distributors. Cosmos Holdings Inc. is strategically focusing on the R&D of novel patented nutraceuticals (IP) and specialized root extracts as well as on the R&D of proprietary complex generics and innovative OTC products. Management is focused on Branded Pharmaceuticals, Generic Pharmaceuticals, Health Products & Food Supplements, Research & Development, and Local & Direct to Pharmacy Wholesale. Check out the Company’s latest presentation here.

In Q3, 2022 Cosmos reported $12 million in revenues and made a number of important advancements including raising $7.5 million via a public offering, entered into an agreement to restructure its warrents to avoid dilution, announced an agreement to market and distribute Nickelodeon’s SpongeBob and PAW Patrol kids’ vitamins in Greece and Cyprus, aiming to reach out 11,000 pharmacies and 120 wholesalers in Greece and 780 pharmacies in Cyprus and much more. 

COSM Rapid Growth Though Acquisition:

Cosmos has a plan for rapid growth through acquisition; currently the Company is evaluating acquisition targets that allows it to expand its distribution reach and/or vertically integrate into its supply chain of the products. COSM is also actively pursuing accretive acquisitions that offer long-term revenue growth, margin expansion through synergies, and the ability to maintain a flexible capital structure. 

COSM acquisitions currently on the table:  

• Entered into an LOI to acquire ZipDoctor Inc., a direct-to-consumer subscription-based telemedicine platform, that expects to provide its customers affordable, unlimited, 24/7 access to board certified physicians and licensed mental and behavioral health counselors and therapists. 
• Entered into an agreement to acquire LIFE NLB, Ltd.’s product portfolio, including Bone-Vio® and Bone-X, related to bone health targeting the human gastrointestinal microbiome. 
• Entered into a binding letter of intent to acquire Pharmaceutical Laboratories CANA S.A., a Greek pharmaceutical company that manufactures, sells, distributes, and markets original branded products researched and developed by leading global pharmaceutical and healthcare companies. 

Even in a blood red day for $SPY nobody can argue that $COSM is extraordinarily strong.

— Moon 🌑 (@MoonMarket_) December 5, 2022

Recent News: Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company 

On December 2 COSM provided a summary regarding recent share activity, including the participation of CEO, Greg Siokas on all capital raises. Management reiterates its belief in the financial strength of Cosmos Health, and its commitment to the growth and profitability of the Company. 

In February and October of 2022 Cosmos successfully conducted two separate rounds of financings, with the combined proceeds of $13.5M. Furthermore, the Company has noted significant exercises of warrants in the month of November. As such, management now expects that by the end of Year End 2022, debt should decline by roughly 50% versus prior year levels. 

Mr. Siokas has not sold any shares and has no plans to sell any of his shares. 

Greg Siokas, Chief Executive Officer of Cosmos Health stated, “I am excited to see Cosmos emerge in to in a stronger financial position. We have had two successful capital raises in 2022, both of which I happily participated in for a combined amount of $3M. Since 2019, I have invested over $10.6M at an average price of $5.25 of my personal assets in Cosmos, as I have always believed in its growth and profitability prospects. My interests have always been and will continue to be aligned with those of shareholders, and I am constantly working to make sure shareholder value is realized. Given our new financial stability, I am hopeful about the future of Cosmos and our ability to rapidly grow as an international health and wellness company with multiple strong brands. I want to thank our shareholders and our team members who have helped us through this journey.” 

$COSM
Double check your accounts for permission to hypothecate (loan) out your shares. People have been reporting that the brokers turned this permission on without their knowledge.

— Frank Benedetto (@benedetto_frank) December 5, 2022

 For More on COSM Subscribe Right Now!

Currently trading at a $46 million market valuation COSM os is 83,797,481 the Company recently reported Q3 Revenues of $12 million down a bit from the same time last year due to a high variation in FX differences between EUR and GBP to USD. COSM was trading over $4 this time last year however OS has increased substantially since then.  COSM is an exciting opportunity in small caps; the stock was shorted into oblivion and currently there are minimum 10 million shares short and was way oversold to pennies and it looked as if it would definitely get delisted by the Nasdaq however, led by able CEO Grigorios Siokas, Cosmos is fighting back. Mr. Siokas continues to buy more COSM at current price levels, putting his money where his mouth is as COSM rockets towards $1. As for the Nasdaq delisting COSM appealed it and has (until otherwise annouinced) until January 23 to get the bid over $1 We will be updating on COSM when more details emerge so make sure you are subscribed to Microcapdaily.

Disclosure: we hold no position in COSM either long or short and we have not been compensated for this article.

Global Developments, Inc., (OTCMKTS: GDVM) has had another amazing week as the stock continues to rocket northbound. GDVM has been under heavy accumulation ever since Mr. Melvin Ejiogu, an executive who is President of VeeMost Technologies became the controlling shareholder and instituted a new dilution policy, affected a massive share reduction and trapped the market makers who were seriously short. On Friday the stock closed at $0.0898, right off the day’s highs of $0.0899 on just under $1 million in dollar volume booking more than 100% gains over just the past week. 

Reverse merger stocks can be more explosive than biotech’s when the incoming Company has real value but is undiscovered to investors and we have covered many on the website that have gone from pennies to dollars. One recent RM runners that stand out is HRBR which went from a few cents (where we first wrote about it) to $3 plus. GDVM is the perfect reverse merger candidate with a clean balance sheet and is debt free. We first gave the heads up on GDVM when the stock was around $0.003 at the end of October. 

Global Developments, Inc., (OTCMKTS: GDVM) a Delaware corporation was incorporated in Delaware on December 9, 2004 as Autobahn International, Inc., changed its name to Global Developments Inc. on May 30, 2016, and changed its name to Global Developments Holdings, Inc. on September 20, 2018. The Company sought to focus on equity and debt financing opportunities and business acquisitions. The Company has not had any significant operations since 2012. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target businesses. The Company has not identified or selected any Business Combination. As of March 31, 2022, the Company has no significant operations. 36,000 in liabilities.  

$GDVM majority control acquired and all outstanding debt purchased. I also purchased 12% of outstanding shares and returned them to the treasury. No dilution will occur. I’ll be sharing updates soon with everyone on our new journey.

— Melvin Ejiogu (@MelvinEjiogu) September 21, 2022

Mr. Melvin Ejiogu, GDVM controlling shareholder and CEO is also currently serving as the CEO and President of VeeMost Technologies. Mr. Ejiogu owns at least 76.56% of all shares of common stock issued and outstanding. He holds a bachelor’s degree in Business Administration with a specialty in Corporate Finance from the University of Akron in Ohio. Melvin also holds several top-level certifications in the I.T industry, and he is one of the few individuals who have earned the prestigious Cisco Certified Internetwork Expert (CCIE) certification. With over 25 years in the technology industry, Melvin has successfully blended his business acumen with his technical expertise, finding innovate ways to use technology to transform businesses and solve business issues. 

In his partnership with Fit Technologies in Cleveland Ohio where he served as the Director of Business Development and Director for Technology Engineering, Melvin was instrumental in growing the company’s annual revenue from $8M to $28M in a few years. Melvin has provided services to the US Federal Courts, Internal Revenue Service (IRS), United States Airforce, Fidelity Group, and many more. Melvin contracted with AT&T Labs where he served as a Lead Principal Architect & Designer, designing, implementing, and securing network infrastructures and solutions for large government entities and enterprise customers. He is recognized as an expert in delivering Transformation Services to enterprise organizations and was key to AT&T’s multibillion dollar contract with the United States Airforce.  

To Find out the inside Scoop on GDVM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

VeeMost Technologies is a technology service and integration firm with a solid track record of helping our customers design, use, and manage technology to improve business outcomes and transform their businesses. With our deep technical expertise in networking, collaboration, and cyber security, we design solutions to help our clients bridge the gap between legacy investments and new innovations. Some of these include on-premises, hybrid, to cloud architecture that support business requirements and goals. Our services enable us to modernize and manage cloud and on-premise environments as “one” for our customers, enabling them to scale seamlessly. 

In November VeeMost announced its recent achievement of Cisco’s Advanced Enterprise Networks Architecture Specialization. Over the last 6 months, VeeMost has also achieved the Advanced Collaboration Architecture Specialization, Advanced SP Architecture Specialization, and Advanced Security Architecture Specialization. This puts VeeMost Technologies on a path to becoming a Cisco Gold Integrator. 

VeeMost Technologies has again proven to have the ability to provide sophisticated, value-added Cisco solutions through our in-depth sales capabilities, technology skills, and service offerings. The Cisco Advanced Enterprise Networks Architecture Specialization gives VeeMost Technologies the expertise and experience to assist clients in automating application rollouts to reduce risk and free up client IT staff, managing cloud services to enable fast adoptions, broad partner support, and on-demand scale, and virtualizing third-party applications and delivering services on any platform. Congratulations to all VeeMost Technologies Engineers who had their share in these recent achievements and successes. 

VeeMost CEO Melvin Ejiogu said: “Our customers rely heavily on technology. This recent specialization achievement along with the previous three allows us to connect our client’s distributed workforce securely and reliably with Cisco’s solutions, helping keep their business resilient and agile while focusing on speed-to-value in every client engagement. Most importantly, this allows us to target those fortune 500 companies who only do business with Cisco gold partners. It is only a matter of time before the word about our expertise and our customer-first approach gets around.” 

 For More on GDVM Subscribe Right Now!

Currently trading at a $27 million market valuation GDVM OS is 368,333,637 down from 3.5 billion in September. The stock is moving up steadily on a locked float as the market makers scramble for shares in an effort to cover their naked short positions which are now seriously underwater. GDVI is moving northbound with no resistance whatsoever and nobody is selling as this short squeeze heats up fast. We will be updating on GDVM when more details emerge so make sure you are subscribed to Microcapdaily.

Disclosure: we hold no position in GDVM either long or short and we have not been compensated for this article.

Cann American Corp (OTCMKTS: CNNA) rocketed into copperland on Friday making new 52-week highs of $0.0149 and closing at $0.146 up 114% on the day on just over $700,000 in dollar volume setting up for an enormous week ahead. CNNA has been making one big move after another ever since new CEO Mr. Alexander Woods-Leo took over the Company with the acquisition of 80% of video game creator Mark2media Group. CNNA also recently acquired 75% of Valkyrie Systems Inc (US Military&DOD Spec Ops Trng Contracts) and is in 3rd round talks to acquire a majority stake in a Drone Company with a valuable intellectual property portfolio. 

Currently expert market, CNNA is about to go “pink current” as well as affect a significant authorized share reduction to 500 million common shares. Earlier this year the Company cancelled 3.3 million shares of common stoc as well as successfully signed a debt settlement agreement that is effective December 21, 2022. The total amount of debt was about $98,000 convertible at .0001. Management worked with the debt holder to change the conversion to .001. There are still a few other reductions the company is seeking to make going forward. CNNA is currently in talks to raise $2 million in bridge capital with a registered institution above .01 per share. Management has previous successful business dealings with the institution. 

Cann American Corp (OTCMKTS: CNNA) was originally incorporated in Wyoming in 2013 as and Bioflamex Corp before changing its name to Canamed4Pets, Inc. The new Comapny; Mark2media Group a video game creator is a technology company with a vision to develop and distribute applications globally under a unique business model that eliminates heavy end user costs. Mark2 is registered with Google Play, Apple Store, Steam and Oculus. Mark2 launched its first game, Infinite Dragoon, in September of 2021 and has received thousands of Google Play and Apple Store downloads. Mark2’s next game, Dragon Caster: Age of Infinity, is in the final stages of development and has already received over 10,000 sign ups. New management intends to rapidly expand Cann American into a diversified holding company. In addition to the Mark2 acquisition, the Company is currently negotiating additional acquisitions and preparing for additional board appointments. 

The shares, previously issued to a third-party investor, were returned to treasury, and will immediately reflect a reduction of outstanding shares. As previously announced, which is a continuation of the company’s commitment to build shareholder value, the company cancelled a $30,000 convertible note. The note was purchased from a third party by CEO Jason Black in a private transaction. The company also announced on January 3, 2022, that it has also hired a PCAOB registered auditor to audit two years of financial statements so that the company can complete and file a Form 10 with the SEC to become a fully reporting company. 

On November 2 CNNA completed the asset purchase of Mark2media group as a majority owned subsidiary of Cann American Corp. Under the terms of the transaction Cann American acquired 80 million common shares of Mark2media Group, constituting 80% majority ownership in Mark2, in exchange of 1,500,000 series B preferred shares of Cann American. 

It’s the first time Mr. Alexander M. Woods-Leo (this is the 4th pubco) has had to deal with this. Apparently OTC Markets has upped their due diligence process during the application process. I don’t know the minimum limit I just know we were requested at 64% held at Cede & Co https://t.co/XPT3i1b0JN

— CNNA (@CNNA_OTC) December 2, 2022

To Find out the inside Scoop on CNNA Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

In addition to the Mark2 acquisition, the terms of the deal will see current CEO, Jason Black, step down as a Director and Officer of the Company and Mr. Alex Woods-Leo appointed as new Director and CEO. Mr. Alexander Woods-Leo is a published developer and patent holder with over a decade of experience with public companies and financial services. Mr. Woods-Leo also currently serves as a Director and CEO of Mark2media Group.

Assets such as the Company’s 20% stake in Cannagram are expected to remain with the Company as management believes that Mark2’s technology experience will greatly enhance the goals of Cannagram to expand into a technology driven cannabis delivery application.  Finally, the Company intends to restructure previous debt arrangements in order to preserve the Company’s capital structure and shareholder value, while immediately beginning the audit process for the sake of up listing to the OTCQB exchange. Additional updates will be forthcoming. 

Stated Cann American CEO, Alexander Woods-Leo: “I’m very excited for the opportunity to embark on this new era for Cann American and its shareholders. I have a bold new vision and direction for the Company and look forward to a bright future for Cann American.” 

$CNNA we have started the Form 10 registration statement draft as per last filing with Wyoming SOS the board authorized the Form 10 #business #OTCMarkets #OTCQB pic.twitter.com/KyysXBVx84

— CNNA (@CNNA_OTC) December 2, 2022

For more on CNNA Subscribe Right Now!

Currently trading at a $1.6 million market valuation CNNA is a low float reverse merger play that is on fire after the Company closed on the 80% stake in video game creator Mark2media. The new CEO; Mr. Alex Woods-Leo has an ambitious vision to rapidly expand Cann American into a diversified holding company and is currently negotiating additional acquisitions and preparing for additional board appointments. He is also getting the books audited in an effort to uplist to fully reporting OTCQB and “pink current” is imminent. Currently on a blue sky breakout, CNNA is quickly attracting a loyal following who swear this one goes way higher. We will be updating on CNNA when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CNNA.

Disclosure: we hold no position in CNNA either long or short and we have not been compensated for this article.